When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CELG - Celgene And Acceleron: BLA Luspatercept Has Strong Potential
Celgene Corporation
Celgene (CELG) and its partner Acceleron Pharma (XLRN) announced that they had submitted their BLA for their biologic luspatercept to the FDA for potential regulatory approval. The BLA to the FDA will be for two different diseases associated with anemia. In addition, a regulatory submission to the European Medicines Agency ((EMA)) is also set to be submitted in the coming months also. The main goal is to get luspatercept approved for the first few indications and, then, target the same patients who are at lower risk. This would greatly expand upon